Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Spironolactone
Treatment for Alcoholic cardiomyopathy
Typical Dosage: 12.5-25mg daily, titrated to 50mg daily
Effectiveness
70%
Safety Score
65%
Clinical Trials
1
Participants
15K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
12.5-25mg daily, titrated to 50mg daily
Time to Effect
4-8 weeks
Treatment Duration
lifetime
Evidence Quality
HIGHNumber Needed to Treat (NNT)
20(Treat 20 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
15(Treat 15 patients to see 1 additional serious adverse event)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$80
Monitoring:$400
Side Effect Mgmt:$100
Total Annual:$580
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$10,000/QALY
QALYs Gained
0.5
Outcome-Based Costs
Cost per Responder
$1,055
Comparison vs Placebo
Cost Difference
+$580/year
More expensive
QALY Difference
+0.50 QALYs
Better outcomes
Dominance
No dominance
Spironolactone Outcomes
for Alcoholic cardiomyopathy
Efficacy Outcomes
Overall Effectiveness
+70%
Response Rate
+55%
Common Side Effects
Hyperkalemia
+12%
Gynecomastia
+7%
Hypotension
+5%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov